Sphingosine kinase 1 inhibition sensitizes hormone‐resistant prostate cancer to docetaxel
Open Access
- 11 June 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 125 (11), 2728-2736
- https://doi.org/10.1002/ijc.24640
Abstract
It has recently been shown that docetaxel chemotherapy is effective in prolonging life in patients with prostate cancer (PCa). We have investigated potential ways of increasing the effectiveness of chemotherapy in this disease. We have previously reported that sphingosine kinase 1 (SphK1) inhibition is a key step in docetaxel‐induced apoptosis in the PC‐3 PCa cell line and that pharmacologicalSphK1 inhibition is chemosensitizing in the docetaxel‐resistant PCa LNCaP cell line. In this study we have addressed the mechanism of docetaxel‐induced apoptosis of PC‐3 cells and identified SphK1‐dependent and ‐independent components. We have shown that SphK1 inhibition by docetaxel is a two‐step process involving an initial loss of enzyme activity followed by a decrease in SphK1 gene expression. Using hormoneresistant PC‐3 and DU145 PCa cells we have demonstrated that both pharmacological and siRNA‐mediated SphK1 inhibition leads to a four‐fold decrease in the docetaxel IC50 dose. This work points out to potential ways of increasing the effectiveness of chemotherapy for PCa by SphK1 inhibition. © 2009 UICCKeywords
This publication has 43 references indexed in Scilit:
- A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemiaBlood, 2008
- Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancerBreast Cancer Research and Treatment, 2007
- Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL‐2‐independent apoptosis in human prostatic adenocarcinoma cellsThe Prostate, 2007
- Sphingosine kinase-1 – a potential therapeutic target in cancerAnti-Cancer Drugs, 2007
- Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse ModelsCancer Research, 2005
- Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1Leukemia, 2005
- Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor‐induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12Journal of Neurochemistry, 2005
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Sphingosine-1-phosphate: an enigmatic signalling lipidNature Reviews Molecular Cell Biology, 2003
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997